“Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review”. The Review of Diabetic Studies , Feb. 2025, pp. 1039-48, https://doi.org/10.70082/x94dvz94.